Bifogade filer
Sedana Medical Annual Report 2025
sedanamedicalab-2025-12-31-1-sv
Prenumeration
Kalender
| Est. tid* | ||
| 2026-10-22 | 07:00 | Kvartalsrapport 2026-Q3 |
| 2026-07-17 | 07:00 | Kvartalsrapport 2026-Q2 |
| 2026-05-28 | N/A | X-dag ordinarie utdelning SEDANA 0.00 SEK |
| 2026-05-27 | N/A | Årsstämma |
| 2026-04-23 | 07:00 | Kvartalsrapport 2026-Q1 |
| 2026-02-12 | - | Bokslutskommuniké 2025 |
| 2025-10-24 | - | Kvartalsrapport 2025-Q3 |
| 2025-07-18 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-16 | - | X-dag ordinarie utdelning SEDANA 0.00 SEK |
| 2025-05-15 | - | Årsstämma |
| 2025-05-06 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-13 | - | Bokslutskommuniké 2024 |
| 2024-10-24 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-23 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-23 | - | X-dag ordinarie utdelning SEDANA 0.00 SEK |
| 2024-05-22 | - | Årsstämma |
| 2024-04-25 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-21 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-17 | - | X-dag ordinarie utdelning SEDANA 0.00 SEK |
| 2023-05-16 | - | Årsstämma |
| 2023-04-27 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-16 | - | Bokslutskommuniké 2022 |
| 2022-10-25 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-21 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-12 | - | X-dag ordinarie utdelning SEDANA 0.00 SEK |
| 2022-05-11 | - | Årsstämma |
| 2022-04-28 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-11-04 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-19 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-26 | - | Split SEDANA 1:4 |
| 2021-05-11 | - | X-dag ordinarie utdelning SEDANA 0.00 SEK |
| 2021-05-10 | - | Årsstämma |
| 2021-05-06 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-25 | - | Bokslutskommuniké 2020 |
| 2020-11-05 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-25 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-20 | - | X-dag ordinarie utdelning SEDANA 0.00 SEK |
| 2020-05-19 | - | Årsstämma |
| 2020-05-07 | - | Kvartalsrapport 2020-Q1 |
| 2020-03-05 | - | Bokslutskommuniké 2019 |
| 2019-11-13 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-22 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-29 | - | X-dag ordinarie utdelning SEDANA 0.00 SEK |
| 2019-05-28 | - | Årsstämma |
| 2019-05-08 | - | Kvartalsrapport 2019-Q1 |
| 2019-03-21 | - | Bokslutskommuniké 2018 |
| 2018-11-22 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-30 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-23 | - | X-dag ordinarie utdelning SEDANA 0.00 SEK |
| 2018-05-22 | - | Årsstämma |
| 2018-05-22 | - | Kvartalsrapport 2018-Q1 |
| 2018-03-27 | - | Bokslutskommuniké 2017 |
| 2017-11-30 | - | Kvartalsrapport 2017-Q3 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Small Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
Sedana Medical AB’s (publ) Annual Report describes important events and financial information for 2025, as well as the progress the company has made on its strategic priorities during the year.
“2025 was a successful year for Sedana Medical. For the first time as a listed company, we achieved profitability in our core business outside the United States, demonstrating the strength of our transformed operating model and establishing a stable, cash generating foundation for continued growth. At the same time, we made significant progress in reducing the risks related to US approval, including successful pivotal trials, FDA authorization of the Early Access Program, and positive regulatory interactions.", says Johannes Doll, President and CEO of Sedana Medical.
The Annual Report is available at www.sedanamedical.com.
For additional information, please contact:
Johannes Doll, CEO, +46 (0)76 303 66 66
Johan Spetz, CFO, +46 (0)730 36 37 89
[email protected]
This information is information that Sedana Medical AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-04-14 18:00 CEST.
About Sedana Medical
Sedana Medical AB (publ) is a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient’s life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care.
Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, and Spain. In other parts of Europe as well as in Asia, Australia, Canada, and South- and Central America, the company works with external distributors.
Sedana Medical was founded in 2005, is listed on Nasdaq Stockholm (SEDANA) and headquartered in Stockholm, Sweden.